FolusoNOgunleyeMD

Physician

Dr. Ogunleye is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
6190 S Fort Apache Rd
Las Vegas, NV 89148
Phone+1 702-724-8787

Fax+1 480-882-5018

Dr. Foluso Ogunleye is an oncologist at the Optumcare Cancer Center, in Las Vegas, NV and is affiliated with multiple hospitals in the area, including UMC, Saint Rose Dignity hospitals, Southern Hill Hospital, Mountain View Hospital, Sunrise Hospital, and the Valley Hospitals system. He received his medical degree from University of Benin Faculty of Medicine and has been in practice 16 years. He specializes in hematologic oncology and is experienced in neuro-oncology, amyloidosis, hematologic oncology, breast cancer, and prostate cancer.

Corewell Health East Beaumont (Royal Oak)Fellowship, Hematology and Medical Oncology, 2014 - 2017
Roger Williams Medical CenterResidency, Internal Medicine, 2005 - 2008
University of Benin Faculty of MedicineClass of 2001

PubMed

55 citations
Male BRCA mutation carriers: clinical characteristics and cancer spectrum.
Mohammed Ibrahim, Siddhartha Yadav, Foluso Ogunleye, Dana Zakalik
BMC Cancer. 2018-02-13
Unusual Presentation of a Small-Cell Variant of Anaplastic Large-Cell Lymphoma Case: When a Septic Picture Is Not Sepsis
Zhou Yu, Yifan Pang, Linda Wang, Daniel Ezekwudo, Foluso Ogunleye
Case Reports in Hematology. 2017-09-24
Reply to S.E. Langabeer.
Foluso Ogunleye, James Huang, Mohammed Ibrahim, Emily Allen, Neil Brennan
Journal of Oncology Practice. 2017-02-14

Journal Articles

Ibrutinib as a Bruton's Tyrosine Kinase Inhibitor in the management of Chronic Lymphocytic Lymphoma
Ogunleye Foluso, MD Alexander Glick, MD Michael Stender, MD Ishmael Jaiyesimi, DO, Clinical lymphoma Myeloma and Leukemia
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advance Non-Small Cell Lung Cancer. A paradigm shift in Stage IV NSCLC treatment
Foluso Ogunleye, MD Mohammed Ibrahim, MD Michael Stender, MD Gregory Kalemkeriam, MD Ishmael Jaiyesimi DO, American Journal of Hematology/Oncology, 1/16/2015

Abstracts/Posters

Programmed cell death-1/Programmed cell death ligand-1(PD-1/PD-L1) inhibitors, heralding a new era of immunotherapy in the management of advanced Non-Small Cell Lung C...
Foluso Ogunleye, LeAnn Blankenship, Vanessa Millisor, Joseph Anderson, Ishmael Jaiyesimi, ancer Treatment and Research Communications, Volume 12, 2017, Pages 6-13, ISSN 2468-2942, https://doi.org/10.1016/j.ctarc.2017.05.002., 5/2/2017
Treatment patterns for resected gastric cancer using the National Cancer Database.
Foluso Nelson Ogunleye, Karna Tushar Sura, Leann Blankenship, Daniel Ezekwudo, Bolanle Gbadamosi, Ishmael A. Jaiyesimi, and Peyman Kabolizadeh, Journal of Clinical Oncology 2017 35:15_suppl, 4061-4061, 5/1/2017

Member, Clinical trial review committee Rose Cancer Treatment Center 2015 - 2016